ClinicalTrials.gov
public full text
Public Domain
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
breast-cancercancerendometrial-cancerlung-cancermelanomaneoplasmsnon-small-cell-lung-cancerovarian-cancer
The goal of this Phase 1 clinical research study is to find the highest safe dose of BIND-014 that can be given in the treatment of patients with advanced or metastatic cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors#1102496
- First in Human Study of TUB-030 in Patients With Advanced Solid Tumors#884376
- A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors#844281
- Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma#918548
- A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors#879824
Record · ID 1138601
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive